Vimarsana
Biggest News Aggregation in the World

Page 50 - Technology Analytics Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Analytics Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Analytics Solutions Today - Breaking & Trending Today

IQVIA Holdings, Inc. - Consensus 'Buy' rating and 33.4% Upside Potential - Vimarsana News

IQVIA Holdings, Inc. - Consensus 'Buy' rating and 33.4% Upside Potential

IQVIA Holdings, Inc. - Consensus 'Buy' rating and 33.4% Upside Potential

IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance - Vimarsana News

IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance

Revenue of $3,739 million for the fourth quarter, $14,410 million for the full yearGAAP Net Income of $227 million for the fourth quarter, $1,091 million for the full yearAdjusted EBITDA of $920 million for the fourth quarter, $3,346 million for the full yearGAAP Diluted Earnings per Share of $1.20 for the fourth qu...

2,749 Shares in IQVIA Holdings Inc. (NYSE:IQV) Acquired by Ritholtz Wealth Management - Vimarsana News

2,749 Shares in IQVIA Holdings Inc. (NYSE:IQV) Acquired by Ritholtz Wealth Management

Ritholtz Wealth Management acquired a new position in IQVIA Holdings Inc. (NYSE:IQV – Get Rating) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,749 shares of the medical research company’s stock, valued at approximately $498,000. A number of other […]

US Bancorp DE Purchases 1,655 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Vimarsana News

US Bancorp DE Purchases 1,655 Shares of IQVIA Holdings Inc. (NYSE:IQV)

US Bancorp DE grew its position in IQVIA Holdings Inc. (NYSE:IQV – Get Rating) by 9.2% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 19,651 shares of the medical research company’s stock after buying an additional 1,655 shares during the period. US Bancorp DE’s holdings […]

IQVIA (NYSE:IQV) Price Target Raised to $275.00 - Vimarsana News

IQVIA (NYSE:IQV) Price Target Raised to $275.00

IQVIA (NYSE:IQV – Get Rating) had its price objective hoisted by equities researchers at Argus from $260.00 to $275.00 in a research report issued to clients and investors on Thursday, The Fly reports. Argus’ price objective indicates a potential upside of 15.05% from the company’s previous close. Other research analysts have also issued reports about […]